⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9097483 | 0.87 | MEN1 (0.31) | — | |
| SCHEMBL6853828 | 0.84 | — | — | |
| SCHEMBL2760826 | 0.84 | — | — | |
| SCHEMBL3155628 | 0.82 | — | — | |
| SCHEMBL2495779 | 0.82 | — | — | |
| SCHEMBL9564557 | 0.81 | — | — | |
| SCHEMBL8435140 | 0.79 | — | — | |
| SCHEMBL9341122 | 0.72 | — | — | |
| SCHEMBL7651773 | 0.70 | — | — | |
| SCHEMBL29471028 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3262022-B1 | PHENYLETHYNYLNAPHTHALENE DYES AND METHODS FOR THEIR USE | SONY GROUP CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-3262055-B1 | WATER SOLUBLE FLUORESCENT OR COLORED DYES COMPRISING CONJUGATING GROUPS | SONY GROUP CORP (JP) | 2026-04-22 | — | — | EP | disclosed |
| EP-4716745-A1 | NEW TLR-4 ANTAGONIST APTAMERS | Merck Patent GmbH (DE) | 2026-04-01 | — | — | EP | disclosed |
| US-12578342-B2 | Polymeric dyes having a backbone comprising organophosphate units | Sony Group Corporation (JP) | 2026-03-17 | — | — | US | disclosed |
| US-12577403-B2 | Ultra bright dimeric or polymeric dyes | Sony Group Corporation (JP) | 2026-03-17 | — | — | US | disclosed |
| US-12560612-B2 | Ultra bright dimeric or polymeric dyes with spacing linker groups | Sony Group Corporation (JP) | 2026-02-24 | — | — | US | disclosed |
| US-12539334-B2 | Phosphoalkyl polymers comprising biologically active agents | Sony Group Corporation (JP) | 2026-02-03 | — | — | US | disclosed |
| US-20260028484-A1 | POLYMERIC TANDEM DYES WITH SPACING LINKER GROUPS | SONY GROUP CORP (JP) | 2026-01-29 | — | — | US | disclosed |
| US-20250382465-A1 | POLYMERIC DYES WITH LINKER GROUPS COMPRISING DEOXYRIBOSE | SONY GROUP CORP (JP) | 2025-12-18 | — | — | US | disclosed |
| EP-4137818-B1 | USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS | SONY GROUP CORP (JP) | 2025-12-10 | — | — | EP | disclosed |
| US-20100303802-A1 | ANTIBODY DIRECTED TO G PROTEIN COUPLED RECEPTORS (GPCR) | F. HOFFMANN-LA ROCHE AG (CH) | 2010-12-02 | — | — | US | disclosed |
| EP-1608733-A4 | MODIFIED POLYNUCLEOTIDES FOR USE IN RNA INTERFERENCE | DHARMACON INC (US) | 2008-02-27 | — | — | EP | disclosed |
| EP-1608733-A2 | MODIFIED POLYNUCLEOTIDES FOR USE IN RNA INTERFERENCE | Dharmacon, Inc. (US) | 2005-12-28 | — | — | EP | disclosed |
| US-20050069928-A1 | Methods for synthesis of defined polynucleotides | BLUE HERON BIOTECHNOLOGY, INC. (US) | 2005-03-31 | — | — | US | disclosed |
| WO-2004090105-A2 | MODIFIED POLYNUCLEOTIDES FOR USE IN RNA INTERFERENCE | DHARMACON, INC. (US) | 2004-10-21 | — | — | WO | disclosed |
| US-5714606-A | OLIGONUCLEOTIDE HAVING RECEPTOR BINDING SITES; ENZYME INHIBITORS, ANTIINFLAMMATORY AGENTS, MEDICAL DIAGNOSIS | ISIS PHARMACEUTICALS, INC. (US) | 1998-02-03 | — | — | US | disclosed |
| EP-0739335-A4 | PYRROLIDINE-CONTAINING MONOMERS AND OLIGOMERS | ISIS PHARMACEUTICALS INC (US) | 1997-04-02 | — | — | EP | disclosed |
| EP-0739335-A1 | PYRROLIDINE-CONTAINING MONOMERS AND OLIGOMERS | ISIS PHARMACEUTICALS, INC. (US) | 1996-10-30 | — | — | EP | disclosed |
| US-5519134-A | ANTIINFLAMMATORY AGENTS | ISIS PHARMACEUTICALS, INC. (US) | 1996-05-21 | — | — | US | disclosed |
| WO-1995018792-A1 | PYRROLIDINE-CONTAINING MONOMERS AND OLIGOMERS | ISIS PHARMACEUTICALS, INC. (US) | 1995-07-13 | — | — | WO | disclosed |